We are live on ! Find out more
CA

Centerpoint Advisors Portfolio holdings

AUM $307M
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
+5.82%
1 Year Est. Return
+19.69%
3 Year Est. Return
+61.2%
5 Year Est. Return
+68.15%
10 Year Est. Return
–
AUM
$288M
AUM Growth
+$10.1M
Cap. Flow
-$4.9M
Cap. Flow %
-1.7%
Top 10 Hldgs %
66.82%
Holding
500
New
47
Increased
57
Reduced
79
Closed
18

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$659K
2
AAPL icon
Apple
AAPL
+$210K
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$141K
4
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$113K
5
JEPQ icon
JPMorgan Nasdaq Equity Premium Income ETF
JEPQ
+$42.4K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$1.11M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$743K
3
NVDA icon
NVIDIA
NVDA
+$679K
4
JNJ icon
Johnson & Johnson
JNJ
+$520K
5
IWB icon
iShares Russell 1000 ETF
IWB
+$266K

Sector Composition

Rank Sector Weight
1 Technology 10.12%
2 Communication Services 4.2%
3 Healthcare 3.74%
4 Financials 2.72%
5 Consumer Discretionary 1.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KD icon
451
Kyndryl
KD
$2.99B
$1K ﹤0.01%
51
– –
LFMD icon
452
LifeMD
LFMD
$169M
$1K ﹤0.01%
200
-200
-50% -$1.15K
S icon
453
SentinelOne
S
$6.53B
$1K ﹤0.01%
+40
New +$904
SFIX
454
Stitch Fix
SFIX
$536M
$1K ﹤0.01%
200
– –
SNAP icon
455
Snap
SNAP
$7.89B
$1K ﹤0.01%
77
– –
TGLS icon
456
Tecnoglass
TGLS
$1.93B
$1K ﹤0.01%
+15
New +$870
VOE icon
457
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.7B
$1K ﹤0.01%
+3
New +$477
VTRS icon
458
Viatris
VTRS
$20.4B
$1K ﹤0.01%
84
– –
VTWO icon
459
Vanguard Russell 2000 ETF
VTWO
$17.3B
$1K ﹤0.01%
+9
New +$779
VYM icon
460
Vanguard High Dividend Yield ETF
VYM
$80.9B
$1K ﹤0.01%
8
– –
YARW
461
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$1K ﹤0.01%
7
– –
WAB icon
462
Wabtec
WAB
$49.1B
$1K ﹤0.01%
4
– –
ETH
463
Grayscale Ethereum Staking Mini ETF Shares
ETH
$1.7B
$1K ﹤0.01%
+35
New +$875
AMWL icon
464
American Well
AMWL
$180M
$0 ﹤0.01%
7
-1
-13% -$8
ATI icon
465
ATI
ATI
$25.6B
– –
-314
Closed -$17K
BHF icon
466
Brighthouse Financial
BHF
$3.56B
$0 ﹤0.01%
7
– –
C icon
467
Citigroup
C
$222B
$0 ﹤0.01%
1
– –
CIG icon
468
CEMIG Preferred Shares
CIG
$6.26B
– –
-6
Closed –
CSX icon
469
CSX Corp
CSX
$93.4B
– –
-1,500
Closed -$50K
DEO icon
470
Diageo
DEO
$49B
– –
-236
Closed -$30K
DVYE icon
471
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
– –
-250
Closed -$7K
DXC icon
472
DXC Technology
DXC
$1.82B
– –
-85
Closed -$2K
EMXC icon
473
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.5B
$0 ﹤0.01%
+5
New +$300
FBND icon
474
Fidelity Total Bond ETF
FBND
$26.9B
– –
-816
Closed -$37K
FRSX
475
Foresight Autonomous Holdings
FRSX
$3.9M
$0 ﹤0.01%
2
– –
16 17 18
19
20

Similar funds

TFA
TPG Financial Advisors Portland, Oregon $307M AUM 12.5% 1-Year Est. Return
ITB
Idaho Trust Bank Boise, Idaho $308M AUM 14.24% 1-Year Est. Return
HKIM
Hayek Kallen Investment Management Fairhope, Alabama $307M AUM 18.5% 1-Year Est. Return
ICP
Islander Capital Partners San Francisco, California $308M AUM
PC
Pecaut & Co Sioux City, Iowa $308M AUM 15.9% 1-Year Est. Return
AC
Alfreton Capital Radlett, Hertfordshire, United Kingdom $308M AUM 10.23% 1-Year Est. Return
EWM
Elite Wealth Management Kirkland, Washington $308M AUM 30.88% 1-Year Est. Return
BBWA
Bell & Brown Wealth Advisors Newport Beach, California $308M AUM 36.32% 1-Year Est. Return

Centerpoint Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Centerpoint Advisors held 500 positions worth $288M, up 3.6% from $278M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Centerpoint Advisors's Q3 2024 filing shows 47 new, 57 increased, 79 reduced and 18 closed positions. Its largest new stake was Syros Pharmaceuticals, Inc. Common Stock: 10,659 shares worth $23K. The largest sale was Eli Lilly, an estimated $1.11M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 10% a quarter earlier, followed by Communication Services and Healthcare.

  • Centerpoint Advisors's largest Q3 2024 buy was Syros Pharmaceuticals, Inc. Common Stock: 10,659 shares worth $23K.
  • Centerpoint Advisors added most to iShares Core S&P 500 ETF in Q3 2024, an estimated $659K increase.
  • Centerpoint Advisors's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $1.11M.
  • Centerpoint Advisors fully exited Coca-Cola Femsa in Q3 2024, selling an estimated $96K.
  • Centerpoint Advisors's ten largest holdings make up 67% of its $288M portfolio in Q3 2024.
  • Centerpoint Advisors opened 47 new positions and closed 18 in Q3 2024.
  • Centerpoint Advisors's portfolio value rose 3.6% quarter-over-quarter to $288M.

Based on Centerpoint Advisors's 13F filing for Q3 2024, filed 15 Oct 2024.